Latest posts by Lawrence F Muscarella PhD (see all)
- A Duodenoscope Has Been Linked to ‘Probable Transmission’ of a Colistin-Resistant Superbug In January, the FDA had issued a safety alert reporting a "design issue" with this endoscope "that could increase the risk of patient infection." - December 8, 2017
- FDA Clears A Duodenoscope with a Detachable Cap Almost 20 years ago, the FDA cleared two other duodenoscope models with a reusable distal cover for sale in the U.S. - September 25, 2017
- Air Force Advises 135 Patients of HIV, Hepatitis Infection Risk a Year Later A number of questions about this lapse remain unanswered. - June 26, 2017
“Discussions in Infection Control” is the most replete, and Google’s highest-ranking, infection-control blog in the world. Test it – search for any related topics, and note the high ranking of this blog’s URL” EndoscopeReprocessing.com
— For example, the search engine Bing ranks this blog #1 (visit: Bing.com) when using the search terms “endoscope reprocessing.”
— Or, the search engine Google ranks this blog #1 (visit: Google.com) when using the search terms “Greenville Memorial outbreak.”
More examples of this blog’s high search-engine rankings are provided on this page.
This blog — founded, designed and written by Lawrence F Muscarella, PhD — provides manufacturers and companies with an efficient, targeted, unrivaled and unique platform to optimize the advertising of their infection-control and related products to the audience that is most likely to appreciate and benefit from their products.
Get the biggest bang for your advertising buck — advertise your product in the blog “Discussions in Infection Control.”
Discussions in Infection Control focuses on the control and prevention of healthcare-associated infections (“HAIs”); instrument reprocessing; risk management in the endoscopy suite; and both risk assessments and root cause analyses, among others topics.
This blog is the most comprehensive, read, and focused of its type in the world.
This blog necessarily assures that the company’s targeted advertisement will be seen by a targeted, educated audience, not wasted in the proverbial ether.
Contact Lawrence F Muscarella, PhD, with any questions at: Larry@LFM-HCS.com
No other infection-control and instrument reprocessing blog in the world is viewed by as many healthcare professionals.
The ads’ contracts are binding from month-to-month, or year-to-year, and the manufacturer’s advertisement(s) would be embedded into the text of this blog’s more than 100 articles and side bar.
The cost for non-exclusive advertising is:
— $300 per month (term: month to month), or $3000 (discounted), if the term is for one year, for the placement of your company’s ads into this blog’s articles.
[B.] The cost for exclusive advertising — that is, no other company’s advertisements would appear in this blog’s articles; the company would, in effect, own the blog’s advertising rights, and its company’s ad(s) would appear throughout this blog’s articles — is:
— $1200 per month (term: month to month; or, $14,400 (no discount), if the term is for one year, for the exclusive placement of your company’s ads into this blog’s articles.
- Contact Dr. Muscarella with any questions about placing an ad in “Discussions in Infection Control” by sending email to: